GB/T 16886.9-2017
AbolishedBiological evaluation of medical devices—Part 9: Framework for identification and quantification of potential degradation products
医疗器械生物学评价 第9部分：潜在降解产物的定性和定量框架
Application Summary AI generated
This standard provides a framework for identifying and quantifying potential degradation products from medical devices, ensuring their biological safety. It is applied during the biological evaluation of medical devices, particularly for materials that may degrade over time in the body, such as implants or drug delivery systems. The standard guides manufacturers and testing laboratories in assessing risks associated with degradation byproducts in clinical use.
Related Standards
GB/T 19634-2005
In vitro diagnostic test systems-General technical requirements for blood-glucose monitoring systems for self-testing
GB/T 47486-2026
General technical requirements for vasculature-on-a-chip
GB/Z 30154-2013
Medical laboratories―Guidance on laboratory implementation of GB/T 22576-2008
GB/Z 16886.22-2022
Biological evaluation of medical devices—Part 22:Guidance on nanomaterials
GB/Z 43280-2023
Medical laboratories—Practical guidance for the estimation of measurement uncertainty
GB/Z 43281-2023
Guidance for supervisors and operators of point-of-care testing(POCT) devices
GB/Z 44363-2024
Pyrogenicity—Principles and methods for pyrogen testing of medical devices
GB/Z 157-2026
In vitro diagnostic test systems—Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods
Transparency note: The application summary and key sentences on this page were automatically generated by AI from the standard's original text. This content has not been human-verified and should not be used for compliance or regulatory purposes. Always refer to the official standard document from the issuing authority.